Search Within

Nitya Prabhakar Raj

Formats
  1. Meeting Abstract (63)
  2. Journal Article (35)
  3. Editorial (2)
  4. Guidelines (2)
  5. Review (2)
  6. Correspondence (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (106)
  2. Gastrointestinal Oncology Service (106)
  3. Solid Tumor Oncology Division (106)
  4. Weinberg Fellows (106)
  5. Center for Pancreatic Cancer Research (94)
  6. Department of Pathology and Laboratory Medicine (35)

More Groups

People
  1. Diane Reidy (82)
  2. Marinela Capanu (24)
  3. Joanne Chou (22)
  4. Michael Berger (16)
  5. David Klimstra (14)
  6. Tiffany Le (14)

More People

Years
  1. 2025 (1)
  2. 2024 (12)
  3. 2023 (13)
  4. 2022 (17)
  5. 2021 (12)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Pancreas (27)
  3. Annals of Oncology (4)
  4. Endocrine-Related Cancer (4)
  5. Journal of Vascular and Interventional Radiology (4)
  6. Laboratory Investigation (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. Lippincott Williams & Wilkins (29)
  3. Oxford University Press (8)
  4. Nature Publishing Group (6)
  5. Bioscientifica Ltd (4)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (106)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas
    Meeting Abstract

    Mulvey, C. K.; Hooker, C.; Chan, J. A.; Aggarwal, R. R.; Cinar, P.; Hope, T. A.; Kolli, K. P.; Zhang, L.; Calabrese, S.; Grabowsky, J. A.; more...
    Pancreas (2019)

    Fulltext@MSK | Save
  • Temozolomide in grade 3 neuroendocrine neoplasms (G3 NENs): A multicentre retrospective review
    Meeting Abstract

    Chan, D.; Chan, J.; Halfdanarson, T.; Kunz, P.; McGarrah, P.; Raj, N.; Reidy-Lagunes, D.; Thawer, A.; Whitman, J.; Wu, Y. L.; more...
    Neuroendocrinology (2019)

    Fulltext@MSK | Save
  • Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas
    Meeting Abstract

    Hooker, C.; Chan, J. A.; Aggarwal, R. R.; Cinar, P.; Hope, T.; Kolli, K.; Zhang, L.; Calabrese, S.; Grabowsky, J. A.; Zhang, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing
    Meeting Abstract

    Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Somatostatin receptor-based imaging and treatment of murine pancreatic neuroendocrine tumors induced by MEN1-loss
    Meeting Abstract

    Li, J. W.; Zhang, H.; Carlin, S. D.; Raj, N.; Klimstra, D. S.; Libutti, S. K.; Weber, W. A.; Reidy-Lagunes, D.; Untch, B. R.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability
    Journal Article

    Raj, N.; Shah, R.; Stadler, Z.; Mukherjee, S.; Chou, J.; Untch, B.; Li, J.; Kelly, V.; Osoba, M.; Saltz, L. B.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
    Meeting Abstract

    Yao, J. C.; Strosberg, J.; Fazio, N.; Pavel, M. E.; Ruszniewski, P.; Bergsland, E.; Li, D.; Tafuto, S.; Raj, N.; Campana, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save